Event Partners and Sponsors
Headline Partner
Partner
Partner
Partner
Partner
Free Online Event | 6, 7 and 8 July 2021
Featured Speakers
Peter Henstock
Machine Learning & AI Technical Lead
Pfizer
Dan Ormsby
Senior Consultant
Dotmatics
Paul Nioi
Vice President, Discovery and Translational Research
Alnylam Pharmaceuticals
Nadim Morhell
Director of Automation and Data Management
EnginZyme
Haydn Boehm
Head of Commercial Marketing, Digital Lab Productivity Solutions
Merck Life Science
Dr Annette Hellbach
Director, Head of Science Enablement Tools
Merck Life Science
Philip Romero
Ph.D., Assistant Professor
UW-Madison
Lindsey Rickershauser
Manager, Sales and Marketing Cheminformatics Technologies
Merck Life Science
Jacob Rapp
Graduate Student
UW-Madison
Suneel Kumar BVS
Director of Computational Chemistry, AI
Sai Life Sciences
Christos Varsakelis
Team Lead AI/ML
The Janssen Pharmaceutical Companies of Johnson & Johnson
Alberto Pascual
Director of Data Science and Analytics
IDBS
Ben Miles Ph.D.
Head of Product
Strateos
Tien Luu
Product Manager and Principal Scientific Specialist
BIOVIA
Dr Emma Gardener
Technical Application Scientist
Merck Group
Leveraging data to reduce the cost, time to market
and failure rate of the traditional drug discovery process
and failure rate of the traditional drug discovery process
It is a commonly quoted statistic that the average cost to bring a new drug to market is 2.6bn, and that only 10% of drug candidates make it to market after phase 1 trials.
Given its potential to spot patterns that would take researches significantly longer to do, Artificial Intelligence has the potential to both accelerate and reduce the cost of discovering new drugs.
With that in mind, PharmaIQ Live: Transforming Drug Discovery through AI will be focused on:
Given its potential to spot patterns that would take researches significantly longer to do, Artificial Intelligence has the potential to both accelerate and reduce the cost of discovering new drugs.
With that in mind, PharmaIQ Live: Transforming Drug Discovery through AI will be focused on:
- Target identification – combing existing data to identify potential drug targets
- Compounds – identifying existing compounds that might prove useful, ruling out those with undesirable characteristics and predicting the properties of potential compounds
- Data integration – effectively integrating data from disparate sources such as patient data, research papers to identify patterns and opportunities
- Enhancing efficiency – by removing the burden of high volume, low value tasks in the lab
- Training – upskilling existing drug development scientists on how best to use AI to best effect
Transforming Drug Discovery through AI Agenda 2021
DAY ONE l 6th July 2021
09.00am EST Dotmatics Platform & Adventures in AIDan Ormsby, Senior Consultant, Dotmatics
10.00am EST How Tech Has Been Adopted to Enable Companies to Transfer to Digital
Haydn Boehm, Head of Commercial Marketing -Connected Lab, Merck Life Science
Dr. Emma Gardener, Manager, Sales and Marketing Cheminformatics Technologies, Merck Life Science
Annette Hellbach, Director, Head of Science Enablement Tools, Merck Life Science
11.00am EST Transforming Protein Engineering Through AI Enabled Smart Connected Labs
Session Reserved for Ben Miles, Ph.D., Head of Product, Strateos
Philip Romero, Ph.D., Assistant Professor UW-Madison
Jacob Rapp, Graduate Student UW-Madison
DAY TWO l 7th July 2021
9.00am EST Fireside chat: The Honest Truth about the challenges associated with Implementing AI in Drug Discovery
Christos Varsakelis, Team Lead, Artificial Intelligence and Machine Learning, J&J
10.00am EST Join the digital transformation revolution by democratizing the use of advanced analytics!
Alberto Pascual, Director of Data Science and Analytics, IDBS
11.00am EST How can scientists accelerate drug design and biologics formulation using molecular modelling and machine learning?
Session Reserved for Tien Luu, Product Manager and Principal Scientific Specialist, and Anne Groupil-Lamy, Principal Field Application Scientist and Science Council Fellow BIOVIA at Dassault Systèmes
12.00am EST Understanding the Practical Challenges of Implementing AI and Biocatalysis
Nadim Morhell, Director of Automation and Data Management, EnginZyme
DAY THREE l 8th July 2021
9.00am EST Deep Learning approaches in Drug Design
Suneel Kumar BVS, Director of Computational Chemistry, AI, Sai Life Sciences
10.00am EST FIRESIDE CHAT: Applications of AI in the Discovery of Targets
Paul Nioi, Vice President, Discovery and Translation Research, Alnylam Pharma
11.00am EST JOINT CASE STUDY: Patent Scope Visualization: A Patent Mining and Visualization Platform for Antibody Claims
Peter Henstock, AI and ML Lead, Pfizer + Research Lead
Who should attend?
Pharma IQ Live is designed for Heads / General Managers / Directors of
Artificial Intelligence
Data
Drug Discovery
Discovery Informatics
Research and Development
Science & Technology
Who attends Pharma IQ Live online events
Step 1: Register
Click on any of the register buttons on this page. Enter your information and secure your place
Step 2: Confirmation Email
This will be dispatched upon registration and will contain information like how to login
Step 3: Schedule Time
Mark the time in your calendar so you can be free of distractions to watch the presentations
Step 4: Watch the Event
Click the link in the confirmation email and prepare questions for our industry-leading speakers
Get Involved with Pharma IQ Live
For more information on how Pharma IQ is uniquely placed to help you shape and deliver your message to your target audience - contact us now!
In Partnership With :
©2024 IQPC. All rights reserved.
